Summary
The effects of intracarotid (i. c.) infusions of the adenosine deaminase inhibitor, erythro-9-(2-hydroxy-3nonyl)adenine (EHNA) and of the adenosine uptake blocker, dipyridamole on spontaneous ventilation were studied in rats anaesthetized with sodium pentobarbitone. Both EHNA and dipyridamole mimicked the excitatory effect of adenosine on respiration increasing in a dose-dependent manner respiratory ventilation determined as increases in tidal volume (V T), respiratory frequency (f) and minute volume (V E). These excitatory effects were abolished after section of the carotid sinus nerves. The excitatory effect of EHNA on respiration was prevented by adenosine deaminase and antagonized by 1,3-dipropyl-8(p-sulfophenyl)xanthine (DPSPX). DPSPX also antagonized the excitatory effect of dipyridamole on respiration. Both EHNA and dipyridamole in doses virtually devoid of effect on respiration potentiated the excitatory effect of exogenous adenosine on respiration. Two different effects on respiration were observed during i.c. infusions of cumulative doses of DPSPX: one inhibitory, not present in glomectomized animals and another, excitatory, present in both glomectomized and non-glomectomized animals. It is concluded that endogenous adenosine could be involved in respiration mediated through carotid body chemoreceptors and that the nucleoside is inactivated at this level by deamination and uptake.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Agarwal RP, Spector T, Parks RE (1977) Tight-binding inhibitors-IV. Inhibition of adenosine deaminases by various inhibitors. Biochem Pharmacol 26:359–367
Andy RJ, Kornfeld R (1982) The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J Biol Chem 257:7922–7925
Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:808–813
Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D (1987) Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 61:779–786
Biscoe TJ (1971) Carotid body: structure and function. Physiol Rev 51:437–495
Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J (1985) 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors. J Med Chem 28:487–492
Deuticke B, Gerlach E (1966) Kompetitive Hemmung der Adenosin-Desaminase als mögliche Ursache der coronardilatierenden Wirkung einer Pyrimidopyrimidin-Verbindung. Naunyn-Schmiedeberg's Arch Pharmacol 255:107–119
Eldridge FL, Millhorn DE, Waldrop TG, Kiley JP (1983) Mechanism of respiratory effects of methylxanthines. Respir Physiol 53:239–261
Fuller RW, Maxwell DL, Conradson T-BG, Dixon CMS, Barnes PJ (1987) Circulatory and respiratory effects of infused adenosine in conscious man. Br J Clin Pharmacol 24:309–317
Heller LJ, Mohrmann DE (1987) Estimates of interstitial adenosine in isolated rat hearts from surface exudates during rapid pacing and EHNA infusion. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York, pp 425–434
Henderson JF (1983) Mechanisms of toxicity of adenosine, 2′deoxyadenosine, and inhibitors of adenosine deaminase. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. Martinus Nijhoff Publishers, Boston, pp 223–234
Hopkins SV, Goldie RG (1971) A species difference in the uptake of adenosine by heart. Biochem Pharmacol 20:3359–3365
Jarvis SM, Martin BW, Ng AS (1985) 2-Chloroadenosine, a permeant for the nucleoside transporter. Biochem Pharmacol 34:3237–3241
Klabunde RE (1983) Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 93:21–26
Kukovetz WR, Pöch G (1970) Inhibition of cyclic- 3′,5′-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn-Schmiedeberg's Arch Pharmacol 267:189–194
Maxwell DL, Fuller RW, Nolop KB, Dixon CMS, Hughes JMB (1986) Effects of adenosine on ventilatory responses to hypoxia and hypercapnia in humans. J Appl Physiol 61:1762–1766
Maxwell DL, Fuller RW, Conradson T-B, Dixon CMS, Aber V, Hughes JMB, Barnes PJ (1987) Contrasting effects of two xanthines, theophylline and enprofylline, on the cardio-respiratory stimulation of infused adenosine in man. Acta Physiol Scand 131:459–465
McQueen DS, Ribeiro JA (1981) Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol 74:129–136
McQueen DS, Ribeiro JA (1983) On the specificity and type of receptor involved in carotid body chemoreceptor activation by adenosine in the cat. Br J Pharmacol 80:347–354
McQueen DS, Ribeiro JA (1986) Pharmacological characterization of the receptor involved in chemoexcitation induced by adenosine. Br J Pharmacol 88:615–620
Monteiro EC, Ribeiro JA (1987a) Ventilatory effects of adenosine mediated by carotid body chemoreceptors in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 335:143–148
Monteiro EC, Ribeiro JA (1987b) Adenosina e respiração espontanea: efeitos mediados pelos quimioreceptores do corpo carotideo. Rev Farmacol Clin Exp 4:58
Newby AC (1981) The interaction of inhibitors with adenosine metabolising enzymes in intact isolated cells. Biochem Pharmacol 30:2611–2615
Olsson RA (1987) Intra-arterial adenosine deaminase: a tool for assessing physiologic functions of adenosine. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York Tokyo, pp 438–444
Phillis JW, DeLong RE, Towner JK (1985) Adenosine deaminase inhibitors enhance cerebral anoxic hyperemia in the rat. J Cereb Blood Flow Metabol 5:295–299
Plunkett W, Alexander L, Chubb S, Loo TL (1979) Comparison of the activity of 2′-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo. Biochem Pharmacol 28:201–206
Reid PG, Watt AH, Routledge PA, Smith AP (1987) Intravenous infusion of adenosine but not inosine stimulates respiration in man. Br J Clin Pharmacol 23:331–338
Ribeiro JA, McQueen DS (1983) On the neuromuscular depression and carotid chemoreceptor activation caused by adenosine. In: Daly JW, Kuroda Y, Phillis JW, Shimizu H, Ui M (eds) Physiology and pharmacology of adenosine derivatives. Raven Press, New York, pp 179–188
Ribeiro JA, Monteiro EC, McQueen DS (1988) The actions of adenosine on respiration. In: Paton DM (ed) Adenosine and adenine nucleotides. Physiology and pharmacology. Taylor & Francis, London, pp 225–232
Robertson D, Biaggioni I, Tseng C-J (1988) Adenosine and cardiovascular control. In: Paton DM (ed) Adenosine and adenine nucleotides. Physiology and pharmacology. Taylor & Francis, London, pp 241–250
Rubio R, Knabb RM, Ely SW, Berne RM (1987) A critique on the use of adenosine deaminase to test the adenosine hypothesis: disregarded implicit assumptions. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York Tokyo, pp 445–451
Runold M, Prabhakar NR, Mitra J, Cherniack NS (1987) Adenosine stimulates respiration by acting on vagal receptors. Fed Proc 46:2970
Schrader J, Berne RM, Rubio R (1972) Uptake and metabolism of adenosine by human erythrocyte ghosts. Am J Physiol 223:159–166
Sebastião AM, Ribeiro JA (1988) On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol 94:109–120
Skolnick P, Nimitkitpaisan Y, Stalvey L, Daly JW (1978) Inhibition of brain adenosine deaminase by 2′-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine. J Neurochem 30:1579–1582
Smellie FW, Davis CW, Daly JW, Wells JN (1979) Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci 24:2475–2482
Sollevi A, Fredholm BB (1983) Influence of adenosine on the vascular responses to sympathetic nerve stimulation in the canine subcutaneous adipose tissue. Acta Physiol Scand 119:15–24
Sollevi A, Ostergren J, Fagrell B, Hjemdahl P (1984a) Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. Acta Physiol Scand 121:165–171
Sollevi A, Lagerkranser M, Irestedt L, Gordon E, Lindquist C (1984b) Controlled hypotension with adenosine in cerebral aneurysm surgery. Anesthesiology 61:400–405
Sollevi A (1986) Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol 27:319–349
Stafford A (1966) Potentiation of adenosine and the adenine nucleotides by dipyridamole. Br J Pharmacol Chemother 28:218–227
Watt AH, Reid PG, Stephens MR, Routledge PA (1987) Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body? Br J Clin Pharmacol 23:486–490
Watt AH, Routledge PA (1985) Adenosine stimulates respiration in man. Br J Clin Pharmacol 20:503–506
Wolberg G, Duncan GS, Zimmerman TP, Schmitges CJ, Deeprose RD (1981) Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA): inhibition of cAMP phosphodiesterase (PDE) at immunosuppressive levels. Fed Proc 40:1097
Zetterström T, Vernet L, Ungerstedt U, Tossman U, Jonzon B, Fredholm BB (1982) Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett 29:111–115
Author information
Authors and Affiliations
Additional information
Send offprint requests to J. A. Ribeiro at the above address
Rights and permissions
About this article
Cite this article
Monteiro, E.C., Ribeiro, J.A. Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats. Naunyn-Schmiedeberg's Arch Pharmacol 340, 230–238 (1989). https://doi.org/10.1007/BF00168974
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168974